Nonacus is a leading provider of genetic testing products headquartered in Birmingham, UK. Collaborating closely with scientists and clinicians, the company is developing a comprehensive precision oncology workflow including support for primary tumor and liquid biopsy analysis with the ultimate goal of creating a world where early cancer diagnosis, detection and management is simple and universally available.
Looking for a particular Nonacus employee's phone or email?
The Nonacus annual revenue was $3 million in 2026.
Chris Sale is the CEO of Nonacus.
50 people are employed at Nonacus.
The NAICS codes for Nonacus are [54171, 541, 54, 541713, 5417].
The SIC codes for Nonacus are [87, 873].